Adrecizumab Phase 1 Trial

Clinical trial NCT02991508 · COMPLETED

Trial details

NCT number: NCT02991508
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-05-23
Primary completion: 2016-09-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.